21 May 2026 - Utrecht
Nazma Ilahibaks | CEO & Co-founder | JAMA Tx
Nazma Ilahibaks, PhD, is CEO and co-founder of JAMA Therapeutics, a preclinical stage cardiac gene therapy spin-off from University Medical Center Utrecht. She has over nine years of experience in non-viral drug delivery for cardiovascular applications and is co-inventor of the deVINCI delivery platform. Her career combines academic research, translational science, business development, and venture building. Before founding JAMA Tx, she supported international public-private partnerships with pharma and medtech and helped advance academic venture creation within the Dutch regenerative medicine ecosystem. She holds a PhD in Regenerative Medicine and an MSc in Drug Innovation from Utrecht University.
| For job seekers | For employers | Join BCF Career Event |
| | SUBSCRIBE TO OUR NEWSLETTER | |
| Powered by: Hyphen Projects Privacy Policy Terms & Conditions Chamber of Commerce: 32110979 |
© Copyright 2025 by Hyphen Projects